4.6 Article

Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor-bearing microparticles: a randomized-controlled phase II trial (the Microtec study)

Related references

Note: Only part of the references are listed.
Letter Hematology

Biased estimation of thrombosis rates in cancer studies using the method of Kaplan and Meier

F. Campigotto et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)

Article Hematology

Single vs. swarm detection of microparticles and exosomes by flow cytometry

E. Van der Pol et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)

Article Medicine, General & Internal

Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer

Giancarlo Agnelli et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Hematology

Tissue Factor-Bearing Microparticles and Thrombus Formation

Jeffrey I. Zwicker et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)

Article Hematology

Atomic force microscopy: a novel approach to the detection of nanosized blood microparticles

Y. Yuana et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)

Letter Hematology

Microparticle-associated tissue factor activity in cancer patients with and without thrombosis

M. E. T. Tesselaar et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)

Letter Hematology

Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer

A. A. Khorana et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)

Article Hematology

Microparticle-associated tissue factor activity: a link between cancer and thrombosis?

M. E. T. Tesselaar et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)

Article Biochemistry & Molecular Biology

Evidence for activation of tissue factor by an allosteric disulfide bond

Vivien M. Chen et al.

BIOCHEMISTRY (2006)